Panagora Asset Management Inc Iveric Bio, Inc. Transaction History

Panagora Asset Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	SELL	$7.07 - $17.5 $12,980 - $32,130	-1,836 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$5.69 - $7.17 $2,469 - $3,111	-434 Reduced 19.12%	1,836 $12,000
Q4 2020 Feb 10, 2021	SELL	$5.65 - $7.66 $2,525 - $3,424	-447 Reduced 16.45%	2,270 $16,000
Q3 2019 Nov 12, 2019	SELL	$1.09 - $1.29 $33,804 - $40,006	-31,013 Reduced 91.94%	2,717 $3,000
Q2 2019 Aug 09, 2019	SELL	$1.21 - $1.48 $997 - $1,219	-824 Reduced 2.38%	33,730 $44,000

Q1 2019 May 15, 2019	BUY	$1.21 - $1.61 $41,810 - $55,631	34,554 New	34,554 $49,000

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.